1-5 of 5
Catherine A. Flynn
Close
Sort by
Journal Articles

Identification of robust predictors for ibrutinib response by multiomics in MYD88-mutated Waldenström macroglobulinemia

Clinical Trials & Observations
Kris Richardson, Jorge J. Castillo, Shayna R. Sarosiek, Andrew R. Branagan, Catherine A. Flynn, Kirsten Meid, Joshua N. Gustine, Xia Liu, Amanda Kofides, Shirong Liu, Julie L. Wolf, Katherine A. Kacena, Christopher J. Patterson, Maria Luisa Guerrera, Nicholas Tsakmaklis, Steven P. Treon, Zachary R. Hunter
Journal: Blood Advances
Blood Adv (2024) 8 (9): 2133–2137.
https://doi.org/10.1182/bloodadvances.2023012111
Published: 2024
Includes: Supplemental data
Journal Articles

A new role for the SRC family kinase HCK as a driver of SYK activation in MYD88 mutated lymphomas

Manit Munshi, Xia Liu, Amanda Kofides, Nickolas Tsakmaklis, Maria Luisa Guerrera, Zachary R. Hunter, M. Lia Palomba, Kimon V. Argyropoulos, Christopher J. Patterson, Alexa G. Canning, Kirsten Meid, Joshua Gustine, Andrew R. Branagan, Catherine A. Flynn, Shayna Sarosiek, Jorge J. Castillo, Jinhua Wang, Sara J. Buhrlage, Nathanael S. Gray, Nikhil C. Munshi, Kenneth C. Anderson, Steven P. Treon, Guang Yang
Journal: Blood Advances
Blood Adv (2022) 6 (11): 3332–3338.
https://doi.org/10.1182/bloodadvances.2021006147
Published: 2022
Includes: Supplemental data
Journal Articles

Response and survival predictors in a cohort of 319 patients with Waldenström macroglobulinemia treated with ibrutinib monotherapy

Clinical Trials & Observations
Jorge J. Castillo, Shayna R. Sarosiek, Joshua N. Gustine, Catherine A. Flynn, Carly R. Leventoff, Timothy P. White, Kirsten Meid, Maria L. Guerrera, Amanda Kofides, Xia Liu, Manit Munshi, Nicholas Tsakmaklis, Zachary R. Hunter, Christopher J. Patterson, Andrew R. Branagan, Steven P. Treon
Journal: Blood Advances
Blood Adv (2022) 6 (3): 1015–1024.
https://doi.org/10.1182/bloodadvances.2021006106
Published: 2022
Includes: Supplemental data
Journal Articles

Multicenter phase 2 study of daratumumab monotherapy in patients with previously treated Waldenström macroglobulinemia

Clinical Trials & Observations
Jorge J. Castillo, Edward N. Libby, Stephen M. Ansell, M. Lia Palomba, Kirsten Meid, Catherine A. Flynn, Carly Leventoff, Christopher B. Hergott, Tomasz Sewastianik, Elizabeth A. Morgan, Ruben Carrasco, Jonathan R. Fromm, Guang Yang, Zachary Hunter, Steven P. Treon
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5089–5092.
https://doi.org/10.1182/bloodadvances.2020003087
Published: 2020
Journal Articles

Ixazomib, dexamethasone, and rituximab in treatment-naive patients with Waldenström macroglobulinemia: long-term follow-up

Clinical Trials & Observations
Jorge J. Castillo, Kirsten Meid, Catherine A. Flynn, Jiaji Chen, Maria G. Demos, Maria L. Guerrera, Amanda Kofides, Xia Liu, Manit Munshi, Nicholas Tsakmaklis, Christopher J. Patterson, Guang Yang, Zachary Hunter, Steven P. Treon
Journal: Blood Advances
Blood Adv (2020) 4 (16): 3952–3959.
https://doi.org/10.1182/bloodadvances.2020001963
Published: 2020